News & Events
Artios attending 38th Annual J.P Morgan Healthcare Conference in San Francisco, January 12-16 2020
| Announcement
Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor
| Press release
Artios Pharma appoints Tania Dimitrova as Chief Business Officer and expands presence in the United States
| Press release
Biotech CEO’s: Can Scientist Founders Remain in Charge?
| Media coverage
‘Putting DNA repair on the map’- Artios CEO interviewed by Labiotech
| Media coverage
Artios Pharma Announces Appointment of Professor Rajesh Chopra as Non-Executive Director
| Press release
BioCentury Emerging Company Profile: Artios – Probing DNA Damage
| Media coverage
